- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05940155
Pattern of Admission of Children With COVID-19 Admitted in Assuit University Children Hospital.
A novel coronavirus was identified following a cluster of cases of pneumonia in Wuhan, China, in December 2019. It rapidly spread as an outbreak there. On the 23rd of January 2020, it was announced that the outbreak constituted apublic health emergency of international concern. Few weeks later, virus spread was recorded worldwide and was announcedas a pandemic by WHO in March 11, 2020.Global spread included Egypt, and the first case was recorded inEgypt onFebruary 14, 2020.Diagnosis of COVID-19 depend on a case definition of suspected and confirmed case.
Implementation of case definition depend on the clinical presentation of the case and on laboratory test as well asradiological finding.The cases will be stratified according to these collective data to different grades of severity.
Mild cases are either asymptomatic or symptomatic with Leucopenia and/or lymphopenia with no radiological evidence of pneumonia (upper respiratory tract illness ± one of the following symptoms: fever < 38, cough,GIT symptoms, myalgia and/or arthralgia).
Moderate cases include patients with leucopenia and/or lymphopenia with clinical and radiological evidence of pneumonia, including fever > 38 °Cwith or without cough and tachypnea (respiratory rate > 60 breaths/min forinfants < 2 months, > 50 breaths/min for infants 2-12 months, > 40 breaths/min for children 1-4 years, > 30 breaths/min for children older than5 years old), and the condition may be associated by moderate to severe dehydration.
Cases are considered as severe and critically ill if any of the following is present: - O2 saturation ≤ 92% despite escalating O2 therapy to maximal allowed 6 L/min - O2 saturation ≤ 90 % at room air - If the patient in septic shock, confused or hemodynamically unstable despite fluid resuscitation - If respiratory manifestations are combined with other organ failure - Chest radiography > 50% lesion or progressive lesion within 24-48 hrs.
Children may play a major role in community-based viral transmission. Available data suggest that children may have more upper respiratory tract involvement (including nasopharyngeal carriage) rather than lower respiratory tract involvement.
The decision of the site of management either at home or in hospital depends on the clinical presentation, requirement for supportive care, potential risk factors for severe disease, and the ability of the patient to self-isolate at home. Supportive treatment including sufficient fluid and calories intake, and additional oxygen supplementation should be used in the treatment of children infected with COVID-19. The aim is to prevent ARDS, organ failure, and secondary nosocomial infections. If bacterial infection is suspected, broad-spectrum antibiotics may be used.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Assiut, Egypt, 71515
- Faculty of Medicine and Surgery At Assiut Univesity
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- All the patients from birth up to 18 years old admitted with suspectedor confirmed cases of covid-19 in AUCH.
Exclusion Criteria:
- : Any patient not suspected or confirmed to have COVID-19
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
mild cases
|
|
|
moderate cases
|
diagnostic test by naso-pharyngel swab to confirm the diagnosis of covid-19 at moderate and severe cases.
|
|
severe cases
|
diagnostic test by naso-pharyngel swab to confirm the diagnosis of covid-19 at moderate and severe cases.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluate pattern of admission of children with covid-19 admitted in Assuit University Children Hospital.
Time Frame: one year
|
Evaluate pattern of admission of children with covid-19 admitted in Assuit University Children Hospital.
|
one year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
- Assess the outcome for children with covid-19 admitted in Assuit University Children Hospital
Time Frame: one year
|
- Assess the outcome for children with covid-19 admitted in Assuit University Children Hospital
|
one year
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Diagnosis of COVID-19
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Assess the Outcome for Children With Covid-19 Admitted in Assuit University Children Hospital
-
Assiut UniversityUnknownAssess the Quality Ofmanagement of Children With Cardiorespiratory Arrest in Assuit University Children Hospital According to the( A H A)Guidelines
-
University Hospital, BrestCompletedIdentify Emerging Health Challenges for Children With Motor Disabilities and Their Parents Facing the COVID-19 PandemicFrance
-
Brain Inflammation CollaborativeColumbia University; Solve ME/CFS Initiative; Care EvolutionRecruitingUnhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation ResearchMultiple Sclerosis | Autoimmune Diseases | Anorexia Nervosa | Psoriasis | Bulimia Nervosa | Endometriosis | Celiac Disease | Crohn's Disease | Traumatic Brain Injury | PANDAS | Sjogren's Syndrome | Autoimmune Encephalitis | Psychiatric Disorder | Dysautonomia | Long COVID | Tourette's Syndrome | Inflammatory Bowel Disease... and other conditionsUnited States
Clinical Trials on RT PCR test of COVID 19
-
BioTeke USA, LLCCSSi Life SciencesCompleted
-
EDP BiotechParagon Rx Clinical, Inc.; iCura Diagnostics, LLCCompleted
-
MP Biomedicals, LLCEDP BiotechCompletedCOVID-19 | SARS-CoV2 InfectionUnited States
-
University of RochesterEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
Fondation LenvalWithdrawn
-
bioLytical LaboratoriesCompletedCOVID-19 | SARS-CoV-2 Infection | COVID-19 Pandemic | COVID-19 Virus Infection | Coronavirus Disease-19United States
-
University Hospital, LilleCompletedCovid19 | SARS-CoV InfectionFrance
-
Centre Hospitalier Universitaire, AmiensUniversity Hospital, Rouen; University Hospital, Montpellier; Central Hospital... and other collaboratorsActive, not recruitingCOVID-19 | Hepatocellular CarcinomaFrance
-
University Hospital, LilleCompleted
-
Centre Hospitalier Universitaire, AmiensCompletedCovid-19 | Respiratory Complication | Lung UltrasoundFrance